Title:
TETRAHYDROQUINAZOLINE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2022/171013
Kind Code:
A1
Abstract:
Disclosed in the present invention is a tetrahydroquinazoline compound. Specifically, disclosed is a compound represented by formula (II) and a pharmacologically acceptable salt thereof.
Inventors:
ZHANG YANG (CN)
WU WENTAO (CN)
GENG KAIJUN (CN)
CHEN SHUHUI (CN)
WU WENTAO (CN)
GENG KAIJUN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2022/074782
Publication Date:
August 18, 2022
Filing Date:
January 28, 2022
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D487/08; A61K31/517; A61P35/00; C07D239/72; C07D403/14; C07D487/10; C07D519/00
Domestic Patent References:
| WO2021037018A1 | 2021-03-04 | |||
| WO2020177629A1 | 2020-09-10 |
Foreign References:
| CN112119075A | 2020-12-22 | |||
| CN111499634A | 2020-08-07 | |||
| CN112105419A | 2020-12-18 | |||
| US20190248767A1 | 2019-08-15 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: OPTICAL COUPLER, COMMUNICATION METHOD AND COMMUNICATION SYSTEM
Next Patent: MESSAGE TRANSMISSION METHOD AND APPARATUS
Next Patent: MESSAGE TRANSMISSION METHOD AND APPARATUS